Burr chastises FDA at second Senate user fee hearing

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsDiagnostics/IVDsMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy